The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Formulation and manufacturability of biologics
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lyophilization and development of solid protein pharmaceuticals
Wang, W. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00423-3 · Cited by 1,175
Remington's pharmaceutical sciences
(1976) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600650641 · Cited by 1,136
Design of Freeze-Drying Processes for Pharmaceuticals: Practical Advice
Tang, X., & Pikal, M. J. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016234.73023.75 · Cited by 972
Challenges in the development of high protein concentration formulations
Shire, S. J., Shahrokh, Z., & Liu, J. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20079 · Cited by 882
Self-citationRational Design of Stable Lyophilized Protein Formulations: Some Practical Advice
Carpenter, J. F., Pikal, M. J., Chang, B. S., & Randolph, T. W. (1997) · Pharmaceutical Research · doi:10.1023/a:1012180707283 · Cited by 683
Challenges in the Development of High Protein Concentration Formulations
Shire, S. J., Shahrokh, Z., & Liu, J. (2010) · Current Trends in Monoclonal Antibody Development and Manufacturing · doi:10.1007/978-0-387-76643-0_9 · Cited by 657
Self-citationMembrane separations in biotechnology
van Reis, R., & Zydney, A. (2001) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(00)00201-9 · Cited by 491
Protein Stability During Freezing: Separation of Stresses and Mechanisms of Protein Stabilization
Bhatnagar, B. S., Bogner, R. H., & Pikal, M. J. (2007) · Pharmaceutical Development and Technology · doi:10.1080/10837450701481157 · Cited by 482
Liu, J., Nguyen, M. D. H., Andya, J. D., & Shire, S. J. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20347 · Cited by 436
Self-citationMechanisms of protein stabilization in the solid state
Chang, L. (., & Pikal, M. J. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21825 · Cited by 326
Cited by
Harding, F. A., Stickler, M. M., Razo, J., & DuBridge, R. (2010) · mAbs · doi:10.4161/mabs.2.3.11641 · Cited by 737
The CamSol method of rational design of protein mutants with enhanced solubility
Sormanni, P., Aprile, F. A., & Vendruscolo, M. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.09.026 · Cited by 494
Utilizing graph machine learning within drug discovery and development
Gaudelet, T., Day, B., Jamasb, A. R., Soman, J., Regep, C., Liu, G., Hayter, J. B. R., Vickers, R., Roberts, C., Tang, J., et al. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab159 · Cited by 313
Considerations for the Design of Antibody-Based Therapeutics
Goulet, D. R., & Atkins, W. M. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.05.031 · Cited by 302
High-concentration protein formulations: How high is high?
Garidel, P., Kuhn, A. B., Schäfer, L. V., Karow-Zwick, A. R., & Blech, M. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.06.029 · Cited by 187
“Manufacturing: There are different methods available for concentrating proteins, but from an industrial perspective and handling, UF/DF (ultra-filtration/dia-filtration) is the most used and appropriate method, considering GMP (Good Manufacturing Practice) and cost aspects [42,58].”
MethodCorchero, J. L., Gasser, B., Resina, D., Smith, W., Parrilli, E., Vázquez, F., Abasolo, I., Giuliani, M., Jäntti, J., Ferrer, P., et al. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.09.001 · Cited by 133
Biodegradable Polymers Derived From Amino Acids
Khan, W., Muthupandian, S., Farah, S., Kumar, N., & Domb, A. J. (2011) · Macromolecular Bioscience · doi:10.1002/mabi.201100324 · Cited by 72
Thakur, G., Hebbi, V., & Rathore, A. S. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120456 · Cited by 31
Metadata
- Authors
- Shire, S. J.
- Venue
- Current Opinion in Biotechnology
- Publisher
- Elsevier BV
- Published
- 2009-12
- Volume
- 20
- Issue
- 6
- Pages
- 708-714
- ISSN
- 0958-1669 (ISSN-L)
- OpenAlex
- W2038052574
- Cited by
- 330
- References
- 37
- FWCI
- 0.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.